Abstract
Cerebrovascular disease (CVD) and idiopathic Parkinson’s disease (PD) frequently occur in the elderly; however, CVD is not frequent in the PD population. The possible relationship between PD and CVD was studied with controversial findings. More specifically, it is unclear whether PD can be protective against the development of vascular disease. To assess the neurosonological examination of a group of PD patients matched with a control group of patients not affected by PD along with the potential risk of developing CVD in the PD group to evaluate any differences. The analysis of the left common carotid artery (CCA) revealed a mean intima-media thickness (IMT) of 0.77 ± 0.21 mm in the PD group and 0.83 ± 0.17 mm in the control group, while the right CCA mean IMT was 0.61 ± 0.17 mm in the PD patients and 0.98 ± 0.18 mm in the control group. The difference was statistically significant in both sides. PD patients show a lower IMT value in older age (70–80 years) and a reduced cardiovascular risk.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Roos RAC, Jongen JCF, van der Velde EA (1996) Clinical course of patients with idiopathic Parkison’s disease. Mov Disord 11(3):236–242
Burton EJ, McKeith IG, Burn DJ, Wiliams DE, O’rien JT (2004) Cerebral atrophy in Parkinson’s disease with and without dementia: a comparison with Alzheimer’s disease, dementia with Lewy bodies and controls. Brain 127:791–800
Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184
Jellinger KA (1996) The neuropathologic diagnosis of secondary parkinsonian syndromes. In: Battistin L, Scarlato G, Caraceni T, Ruggieri S (eds) Advances in neurology, vol 69. Raven Press, New York, pp 293–303
Jellinger KA (1986) Overview of morphological changes in Parkinson’s disease. In: Yahr MD, Bergmann KJ (eds) Advances in neurology, vol 45. Raven Press, New York, pp 1–18
Winikates J, Jankovic J (1999) Clinical correlates of vascular parkinsonism. Arch Neurol 56:98
Rektor I, Rektorová I, Kubová D (2006) Vascular parkinsonism—an update. J Neurol Sci 248:185–191
Ben-Shlomo Y (1995) Marmot MG Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology? J Neurol Neurosurg Psychiatry 58:293–299
Bodenmann P, Ghika J, Van Melle G, Bogousslavsky J (2001) Comorbidité neurologique du parkinsonism. Rev Neurol 157:45–54
Gorell JM, Johnson CC, Rybicki BA (1994) Parkinson’s disease and its comorbid disorders: an analysis of Michigan mortality data, 1970–1990. Neurology 44:1865–1868
Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442
Iwasaki S, Narabayashi Y, Hamaguchi K, Iwasaki A, Takakusagi M (1990) Cause of death among patients with Parkinson’s disease: a rare mortality due to cerebral haemorrhage. J Neurol 237:77–79
Korten A, Lodder J, Vreeling F, Boreas A, van Raak L, Kessels F (2001) Stroke and idiopathic Parkinson’s disease: does a shortage of dopamine offer protection against stroke? Mov Disord 16:119–123
Levine RL, Jones JC, Bee N (1992) Stroke and Parkinson’s disease. Stroke 23:839–842
Mastaglia FL, Johnsen RD, Kakulas BA (2002) Prevalence of stroke in Parkinson’s disease: a postmortem study. Mov Disord 17:772–774
Struck LK, Rodnitzky RL, Dobson JK (1990) Stroke and its modification in Parkinson’s disease. Stroke 21:1395–1399
Gibb WRG, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51:745–752
Fahn S, Elston RL, members of the UPDRS Development Committee (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB (eds) Recent developments in Parkinson’s disease, vol 2. Macmillan, New York, pp 153–163
Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9:179–186
Mahoney FI, Barthel DW (1965) Functional evaluation: the BARTHEL index. Md State Med J 14:61–65
Jacobsson SO, Fowler CJ (1999) Dopamine and glutamate neurotoxicity in cultured chick telencephali cells: effects of NMDA antagonists, antioxidants and MAO inhibitors. Neurochem Int 34:49–62
Nakaso K, Yasui K, Kowa H et al (2003) Hypertrophy of IMC of carotid artery in Parkinson’s disease is associated with l-dopa, homocysteine, and MTHFR genotype. J Neurol Sci 207:19–23
Linnebank M, Moskau S, Farmand S et al (2006) Homocysteine and carotid intima-media thickness in a German population: lack of clinical relevance. Stroke 37:2840–2842
Acknowledgments
Authors would thank Maria Grazia Pavei, English mother language teacher, for providing English language assistance on this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical standard
The authors declare that they acted in accordance with ethical standards laid down in the 1964 Declaration of Helsinki.
Informed consent
Informed consent for publication was obtained from the patient.
Rights and permissions
About this article
Cite this article
Zambito Marsala, S., Gioulis, M., Pistacchi, M. et al. Parkinson’s disease and cerebrovascular disease: is there a link? A neurosonological case–control study. Neurol Sci 37, 1707–1711 (2016). https://doi.org/10.1007/s10072-016-2660-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-016-2660-4